DES Action USA

Last updated

DES Action USA is a national consumer advocacy group, whose mission is to educate and raise awareness about diethylstilbestrol (DES) in the public and medical and legal professions, support the DES-exposed population, and advocate for consumer vigilance and rights. [1]

Contents

History of DES

Diethylstilbestrol molecule ball Diethylstilbestrol molecule ball.png
Diethylstilbestrol molecule ball

DES is a synthetic estrogen, which was, from about 1940, prescribed to women at risk of miscarriage and, later, to promote healthy babies. Medical research has now shown that DES has adverse effects and that the approximately 10 million DES-exposed people are at risk for cancer, infertility, pregnancy complications, and other health problems. [2]

The drug came onto the United States market in 1940 from several manufacturers, since the drug was both unpatented and cheap to produce. Despite research demonstrating possible carcinogenic effects (documented in the 1930s) and its inefficacy for preventing miscarriage in 1953, pharmaceutical companies publicized earlier and more favorable studies in their marketing and promotion. [3] In 1971, medical researchers identified several clusters of rare vaginal cancers in some of the children exposed to DES in utero, now teenagers and young adults. The news was alarming to many of the women who had taken the drug during their pregnancies. [4] [5]

Early DES advocacy

As the women's health movement was developing during the same years, concerned women around the country used the model of local organizing and outreach to find other DES-exposed women and their children (known as DES mothers, sons, and daughters).[ citation needed ]

One of the earliest gatherings was of the DES Information Group, founded by Pat Cody (1923-2010) in 1974, working with the Berkeley Free Clinic in California. Cody's group soon joined with the DES Action Committee of the San Francisco-based Committee for the Medical Rights of Women, and the two groups merged into a Bay-area organization. Similar grassroots organizations were being started in Connecticut, Illinois, Massachusetts, New Jersey, New York, and Pennsylvania. [1]

In February 1978, U.S. Secretary of the Department of Health, Education, and Welfare (HEW), Joseph Califano, convened the National DES Task Force. It was charged with making recommendations for research and continuing treatment for persons exposed to DES. The task force issued a physician advisory in November 1978 recommending doctors review their records and notify patients who were prescribed DES.

Founding

DES Action National (later renamed DES Action USA) formed in 1977 with a meeting of these grassroots groups. The organization incorporated as a non-profit in 1979. [1]

Much of DES Action USA's early work was at local and state levels. Public health grants and legislative efforts supported educational outreach and medical care in California and New York. DES Action USA also successfully lobbied that a Federal Task Force be established. During the 1980s, work at state and national levels resulted in several official National DES Awareness Weeks (1983-1985), continued educational work and outreach efforts, and support for liability litigation cases against manufacturers.

Advocacy and legislation

Aware of the need for national funding for DES research and education, director Nora Cody (daughter of Pat Cody) worked closely with Representative Louise M. Slaughter (D-NY) to draft and support a research bill during the early 1990s. The bill was signed into law in 1992, [6] with a second bill passed in 1998 to support research on the third generation of DES-affected people (the grandchildren of DES mothers). Through the early 2000s, their most high-profile work involved working with the Centers for Disease Control to develop and distribute consumer and health professional medical education materials to communicate the latest research about continuing effects of DES exposure. [1]

In 2014, DES Action USA, facing the aging of its leadership, chose to merge with another medical nonprofit, the MedShadow Foundation, which does similar educational and outreach work but focuses on the risks and long-term adverse effects of many prescription drugs. The decision allowed the DES Action USA Board to step down from administration, while allowing DES Action USA to continue its work and mission. [1]

Related Research Articles

Consumer education is the preparation of an individual to be capable of making informed decisions when it comes to purchasing products in a consumer culture. It generally covers various consumer goods and services, prices, what the consumer can expect, standard trade practices, etc. While consumer education can help consumers to make more informed decisions, some researchers have found that its effects can drop off over time, suggesting the need for continual education. New dimensions of consumer education are also beginning to emerge as people become more aware of the need for ethical consumerism and sustainable consumer behaviour in our increasingly globalized society.

<span class="mw-page-title-main">Diethylstilbestrol</span> Chemical compound

Diethylstilbestrol (DES), also known as stilbestrol or stilboestrol, is a nonsteroidal estrogen medication, which is presently rarely used. In the past, it was widely used for a variety of indications, including pregnancy support for those with a history of recurrent miscarriage, hormone therapy for menopausal symptoms and estrogen deficiency, treatment of prostate cancer and breast cancer, and other uses. By 2007, it was only used in the treatment of prostate cancer and breast cancer. In 2011, Hoover and colleagues reported on adverse health outcomes linked to DES including infertility, miscarriage, ectopic pregnancy, preeclampsia, preterm birth, stillbirth, infant death, menopause prior to age 45, breast cancer, cervical cancer, and vaginal cancer. While most commonly taken by mouth, DES was available for use by other routes as well, for instance, vaginal, topical, and by injection.

<span class="mw-page-title-main">Dental amalgam controversy</span> Debate about the effectiveness and safety of dental amalgam

This discussion of the dental amalgam controversy outlines the debate over whether dental amalgam should be used. Supporters claim that it is safe, effective and long-lasting, while critics argue that amalgam is unsafe because it may cause mercury poisoning and other toxicity.

Bioidentical hormone replacement therapy (BHRT), also known as bioidentical hormone therapy(BHT) or natural hormone therapy, is the use of hormones that are identical on a molecular level with endogenous hormones in hormone replacement therapy. It may also be combined with blood and saliva testing of hormone levels, and the use of pharmacy compounding to obtain hormones in an effort to reach a targeted level of hormones in the body. A number of claims by some proponents of BHT have not been confirmed through scientific testing. Specific hormones used in BHT include estrone, estradiol, progesterone, testosterone, dehydroepiandrosterone (DHEA), and estriol.

<span class="mw-page-title-main">Sexual and reproductive health</span> State of the reproductive system without evidence of disease, disorders, or deficiencies

Sexual and reproductive health (SRH) is a field of research, health care, and social activism that explores the health of an individual's reproductive system and sexual well-being during all stages of their life.

A drug recall removes a prescription or over-the-counter drug from the market. Drug recalls in the United States are made by the FDA or the creators of the drug when certain criteria are met. When a drug recall is made, the drug is removed from the market and potential legal action can be taken depending on the severity of the drug recall.

Peer support occurs when people provide knowledge, experience, emotional, social or practical help to each other. It commonly refers to an initiative consisting of trained supporters, and can take a number of forms such as peer mentoring, reflective listening, or counseling. Peer support is also used to refer to initiatives where colleagues, members of self-help organizations and others meet, in person or online, as equals to give each other connection and support on a reciprocal basis.

The National Women's Health Network (NWHN) is a non-profit women's health advocacy organization located in Washington, D.C. It was founded in 1975 by Barbara Seaman, Alice Wolfson, Belita Cowan, Mary Howell, and Phyllis Chesler. The stated mission of the organization is to give women a greater voice within the healthcare system. The NWHN researches and lobbies federal agencies on such issues as AIDS, reproductive rights, breast cancer, older women's health, and new contraceptive technologies. The Women's Health Voice, the NWHN's health information program, provides independent research on a variety of women's health topics.

<span class="mw-page-title-main">Breast Cancer Action</span> American organization

Breast Cancer Action (BCAction) is a U.S.-based grassroots education and activist organization driven by and supporting people living with breast cancer. It was founded in 1990 by Elenore Pred, Susan Claymon, and Linda Reyes. Based in San Francisco, BCAction is known for understanding breast cancer not as an individual crisis, but a public health emergency, and for their commitment to social justice. The organization's mission is to achieve health justice for all women at risk of and living with breast cancer. BCAction is known for its Think Before You Pink campaign, launched in 2002, which encourages consumers to ask critical questions before buying pink ribbon products and holds corporations accountable for pinkwashing.

Direct-to-consumer advertising (DTCA) refers to the marketing and advertising of pharmaceutical products directly to consumers as patients, as opposed to specifically targeting health professionals. The term is synonymous primarily with the advertising of prescription medicines via mass media platforms—most commonly on television and in magazines, but also via online platforms.

<span class="mw-page-title-main">Dhulikhel Hospital</span> Hospital in Kavrepalanchok District, Nepal

Dhulikhel Hospital, a Kathmandu University hospital, is an independent, not for profit, non-government hospital in Dhulikhel, Kavrepalanchok, Nepal.

<span class="mw-page-title-main">Long-term effects of cannabis</span> Overview of long-term effects of the consumption of cannabis

The long-term effects of cannabis have been the subject of ongoing debate. Because cannabis is illegal in most countries, clinical research presents a challenge and there is limited evidence from which to draw conclusions. In 2017, the U.S. National Academies of Sciences, Engineering, and Medicine issued a report summarizing much of the published literature on health effects of cannabis, into categories regarded as conclusive, substantial, moderate, limited and of no or insufficient evidence to support an association with a particular outcome.

<span class="mw-page-title-main">Breast cancer awareness</span>

Breast cancer awareness is an effort to raise awareness and reduce the stigma of breast cancer through education about screening, symptoms, and treatment. Supporters hope that greater knowledge will lead to earlier detection of breast cancer, which is associated with higher long-term survival rates, and that money raised for breast cancer will produce a reliable, permanent cure.

<span class="mw-page-title-main">Fitness to dive</span> Medical fitness of a person to function safely underwater under pressure

Fitness to dive, specifically the medical fitness to dive, is the medical and physical suitability of a diver to function safely in the underwater environment using underwater diving equipment and procedures. Depending on the circumstances it may be established by a signed statement by the diver that they do not have any of the listed disqualifying conditions and is able to manage the ordinary physical requirements of diving, to a detailed medical examination by a physician registered as a medical examiner of divers following a procedural checklist, and a legal document of fitness to dive issued by the medical examiner.

Toxic abortion is a medical phenomenon of spontaneous abortion, miscarriage, or stillbirth caused by toxins in the environment of the mother during pregnancy, especially as caused by toxic environmental pollutants, though sometimes reported as caused by naturally occurring plant toxins

Sybil Shainwald is an American attorney specializing in women's health law and an activist for women's health reform. She has represented thousands of women and their children in individual and class action suits against manufacturers of harmful drugs, devices, and procedures. Shainwald is former chair of the National Women's Health Network, co-founder of Health Action International and Trial Lawyers for Public Justice.

<span class="mw-page-title-main">Dimestrol</span> Chemical compound

Dimestrol, also known as dianisylhexene, 4,4'-dimethoxy-α,α'-diethylstilbene, diethylstilbestrol dimethyl ether, and dimethoxydiethylstilbestrol, is a synthetic nonsteroidal estrogen of the stilbestrol group which is related to diethylstilbestrol. It has been used clinically as a hormonal therapy in cases of delayed female puberty, hypogonadism, menopausal, and postmenopausal symptoms. It is known to induce the development of female secondary sexual characteristics in the case of female delayed puberty or hypogonadism. The drug has also been used as a growth promoter in livestock.

Diethylstilbestrol (DES), a synthetic nonsteroidal estrogen which was previously used clinically to support pregnancy, has been linked to a variety of long-term adverse effects in women who were treated with it during pregnancy and in their offspring.

Medical reversal refers to when a newer and methodologically superior clinical trial produces results that contradict existing clinical practice and the older trials on which it is based. This leads to an intervention that was widely used falling out of favor, because new evidence either demonstrates that it is ineffective or that its harms exceed its benefits. It is distinct from replacement, which occurs when a newly developed medical treatment supersedes an older, less effective one as the standard of care. Medical reversals are caused when a treatment is widely adopted even when there is not compelling evidence for its safety and effectiveness. For example, an intervention may be adopted because it "makes sense", or because there are observational studies supporting its putative benefits. The negative effects of such reversals include harm to patients who received the intervention when it was considered relatively safe and effective, as well as reducing public trust in medicine.

<span class="mw-page-title-main">Northern Territories Alcohol Labels Study</span> 2017–2018 health research in Yukon, Canada

The Northern Territories Alcohol Labels Study was a scientific experiment in Canada on the effects of alcohol warning labels. It was terminated after lobbying from the alcohol industry, and later relaunched with industry-advocated experimental design changes: omitting the "Alcohol can cause cancer" label, not labelling some alcohol products, and shortening the time period. Enough data was gathered to show that all of the labels used in the study were simple, cheap, and effective, and it recommended that they should be required worldwide.

References

  1. 1 2 3 4 5 "Collection: DES Action USA records | Smith College Finding Aids" . Retrieved 2020-06-09. CC BY icon-80x15.png  This article incorporates text available under the CC BY 3.0 license.
  2. Davidson, Deborah (2003). "Woe the Women: DES, Mothers and Daughters". In Sarah Earle; Gayle Letherby (eds.). Gender, Identity & Reproduction: Social Perspectives. London: Palgrave Macmillan UK. pp. 160–173. doi:10.1057/9780230522930_10. ISBN   978-0-230-52293-0.
  3. Silbersweig, Susan E. (1980). "Payton v. Abbott Laboratories: An Analysis of the Massachusetts DES Class Action Suit". American Journal of Law & Medicine. 6 (2): 243–82. doi:10.1017/S0098858800012570. PMID   7468600. S2CID   34838499.
  4. Duke, Suzanne S.; Mcgraw, Sarah A.; Avis, Nancy E.; Sherman, Amanda (2000). "A focus group study of DES daughters: implications for health care providers". Psycho-Oncology. 9 (5): 439–444. doi:10.1002/1099-1611(200009/10)9:5<439::AID-PON470>3.0.CO;2-L. ISSN   1099-1611. PMID   11038482. S2CID   28366090.
  5. Bell, Susan E. (1999-01-01). "Narratives and Lives: Women's Health Politics and the Diagnosis of Cancer For Des Daughters". Narrative Inquiry. 9 (2): 347–389. doi:10.1075/ni.9.2.08bel.
  6. "DES Education and Research Amendments of 1992 (1992 - H.R. 4178)". GovTrack.us. Retrieved 2020-06-09.